Saturday , February 24 2018
Home / Conditions / Obesity / FDA Approves Maestro Rechargeable System (EnteroMedics) for Treatment of Obesity.

FDA Approves Maestro Rechargeable System (EnteroMedics) for Treatment of Obesity.

Jan 22, 2015
 

The Maestro Rechargeable System is indicated for treatment of patients aged at least 18 years with a BMI of 35 to 45 with at least one obesity-related condition and who have failed to lose weight on a weight loss program. The novel device is the first to target the nerve pathway between the brain and stomach that controls hunger and satiety, according to a press release. See this week’s Item #3.